AstraZeneca Stock And 2 Cash Flow Picks Trading Below Fair Value

With inflation, interest rates and energy prices pulling investors in different directions, solid cash generation and sensible pricing can matter more than ever. That is where the Undervalued Stocks Based On Cash Flows screener comes in. It highlights companies that SWS DCF valuation suggests are trading below fair value, yet still show cash flow potential. This article focuses on that theme and why it can appeal to value oriented investors who want clear, cash backed stories. Keep reading to see 3 of the stocks from this screener that stand out right now.

AstraZeneca (LSE:AZN)

Overview: AstraZeneca is a global biopharmaceutical company headquartered in Cambridge that develops, manufactures, and sells prescription medicines across cancer, cardiovascular and metabolic diseases, respiratory and immunology, vaccines, and rare diseases, working with healthcare providers worldwide to treat serious, often chronic conditions.

Operations: AstraZeneca generates all of its reported revenue from pharmaceuticals, with around US$60.4b coming from prescription medicines.

Market Cap: £195.3b

For investors focused on cash backed value, AstraZeneca presents a mix of solid fundamentals and meaningful tension. Earnings increased 33.7% over the past year, net margins are 17.2%, and return on equity of 21.9% indicates efficient use of capital. At the same time, the stock is indicated as trading below estimated fair value and is supported by a late stage pipeline in oncology and other high need areas. However, heavy reliance on blockbuster drugs, a high debt load, and recent trial setbacks such as Wainua underline the presence of risk. The key consideration is how this combination of cash flow characteristics, pipeline profile, and headline risk relates to the current valuation of AstraZeneca.

AstraZeneca’s cash rich core business and late stage pipeline could be masking what really matters for valuation right now, so it is worth lining up those strengths against the 4 key rewards and 2 important warning signs

Foresight Group Holdings (LSE:FSG)

Overview: Foresight Group Holdings is a London based asset manager that invests in real assets and private equity, with a strong focus on renewable energy, social and digital infrastructure, and smaller growth companies across the UK, Europe, and Australia.

Operations: Foresight Group Holdings generates about £114.8m of revenue from Real Assets and £50.1m from Private Equity, with most revenue coming from the United Kingdom and a meaningful contribution from Australia.

Market Cap: £528.0m

Foresight Group Holdings stands out on this cash flow focused list because it combines high quality earnings and strong return on equity with a growing footprint in renewable and infrastructure assets that many investors want long term exposure to. Earnings grew 34.4% in the past year, net margins sit at 27.7%, and the P/E of 11.6x is below peers, while analysts expect earnings and revenue growth to outpace the wider UK market. At the same time, reliance on performance fees, exposure to UK and European policy changes, and a funding model based on external borrowing introduce genuine risk. The real question is how those buybacks, AUM growth ambitions, and margin targets compare with that risk profile and the current discount to fair value.

Foresight’s earnings momentum and renewable focus are catching attention, but the real story may sit in how that growth profile compares with expectations in the analyst forecasts for Foresight Group Holdings and what that implies for the next phase.

BAE Systems (LSE:BA.)

Overview: BAE Systems is a London based defense and aerospace company that supplies combat aircraft, submarines, ships, vehicles, munitions, electronics, and cyber security services to governments and defense customers across the US, UK, Europe, the Middle East, Australia, and other regions.

Operations: BAE Systems generates most of its revenue from Electronic Systems (£7.5b), Air (£7.4b), Maritime (£6.6b), and Platforms & Services (£5.0b), with smaller contributions from Cyber & Intelligence (£2.4b) and HQ activities.

Market Cap: £53.3b

BAE Systems draws interest from value oriented investors because it blends a large, long dated defense backlog with exposure to higher margin areas such as electronic warfare, advanced munitions, and space systems, highlighted by recent contracts in naval guns, aircraft protection systems, and imaging satellites. Forecast revenue and earnings growth, along with an expected ROE of around 22%, sit alongside a share price that is indicated as trading below estimated fair value, although the P/E remains above sector peers. That potential upside comes with real trade offs, including reliance on a handful of major government contracts, funding that leans on external borrowing, supply chain and capacity bottlenecks, and rising ESG scrutiny, which all matter when assessing how durable this cash flow story really is.

BAE Systems’ rising backlog and higher margin electronics story may only be half the picture, so line that up against the analyst forecasts for BAE Systems to see what could really be driving expectations from here.

The three stocks covered here are just a sampling of the opportunities uncovered. The full Undervalued Stocks Based On Cash Flows screener surfaces 37 more companies that combine discounted pricing with compelling cash flow narratives through the Undervalued Stocks Based On Cash Flows screener. Identify and analyze the specific catalysts, cash flow profiles, and valuation gaps that matter most to you inside Simply Wall St so you can focus on your highest conviction ideas.

Take Control of Your Investment Journey

If BAE Systems or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Before They Fly?

Fresh stock ideas can move from quiet accumulation to full breakout faster than many expect. Use these under the radar lists before the crowd catches on and act now.

• Target resilient compounders with robust balance sheets and steady cash engines by scanning the curated list of solid balance sheet and fundamentals (20 results) while the market focus is elsewhere.
• Explore structural trends in automation and productivity by checking the hand picked 33 robotics and automation stocks that could benefit as global industries upgrade aging systems.
• Consider potential income and defensiveness by reviewing a curated mix of 4 dividend fortresses before yields change or prices move significantly.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com